MENDLEIN JOHN

FATE

MENDLEIN JOHN serves as Director at Fate Therapeutics, Inc. (FATE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$698.1K

Total Sells

2 trades

$1.14M

Net Position

Net Seller

$438.1K

Companies Traded

FATE

Active Period

Mar 2022 – Jan 2023

3 total trades

Most Recent

Buy FATE

Jan 13, 2023 · $698.1K

MENDLEIN JOHN's Insider Trading at Fate Therapeutics, Inc. (FATE)

Buys

1 · $698.1K

Sells

2 · $1.14M

Total Shares Bought

124,679

Total Shares Sold

32,926

FATE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 13, 2023↗	Buy	124,679	$5.60	$698.1K	282,770
Jun 6, 2022↗	Sell	1,364	$22.79	$31.1K	158,091
Mar 11, 2022↗	Sell	31,562	$35.02	$1.11M	171,524

Related Insiders

TAHL CINDY

officer: See Remarks

FATESell · Jan 12, 2026

Bahram Valamehr

director, officer: President and CEO

FATESell · Jan 12, 2026

TAHL CINDY

See Remarks

FATESell · Jan 9, 2026

Bahram Valamehr

President and CEO

FATESell · Jan 9, 2026

Explore More Insider Trading Data

FATE Insider Trading Activity

View all insider trades at Fate Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity